Repros Therapeutics Inc. (Nasdaq: RPRX) commenced an underwritten public offering of up to 3,000,000 shares of its common stock. All ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE